Navigation Links
Video: UCB Launches Vimpat(R) in the U.S. for Add-On Treatment of Epilepsy in Adults
Date:5/26/2009

oom or hospital setting. These formulations are bioequivalent, meaning doses do not need to be adjusted when converting from IV to oral. The IV formulation of Vimpat(R) does not require dilution prior to administration.

Vimpat(R) was approved by the U.S. Food and Drug Administration in October 2008 for the adjunctive treatment of partial onset seizures in patients with epilepsy age 17 and over. Vimpat(R) has been designated as a Schedule V controlled substance by U.S. regulators.

In August 2008, the European Commission approved Vimpat(R) for the adjunctive treatment of partial onset seizures with or without secondary generalization in patients with epilepsy age 16 and over. Vimpat(R) is available in Germany, the U.K., Greece, Austria, Denmark, Sweden, and Netherlands, with other European countries to follow.

Vimpat(R) offers new way of targeting pathways involved in seizure onset

Preclinical studies indicate that Vimpat(R) has a novel mechanism of action, although the precise mechanism by which Vimpat(R) exerts its antiepileptic effect in humans is not yet clear.

In preclinical studies, the mechanism of action for Vimpat(R) has been shown to involve the modulation of sodium channel activity in the nervous system. Sodium channels play a crucial role in regulating the activity of the nervous system to help nerve cells communicate. Sometimes sodium channels are abnormally overactive and nerve cells become too excited, which may produce a seizure. The mechanism of action for Vimpat(R) is thought to reduce this sodium channel over-activity by enhancing the longer lasting inactive state of the channel, a different action compared with current sodium channel blocking drugs. This action then regulates the activity of over-excited nerve cells, which may contribute to the control of seizures.

Preclinical studies also suggest that Vimpat(R) binds to the collapsin response mediat
'/>"/>

SOURCE UCB
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
3. Video: The Arizona Heart Institute Announces the Largest Worldwide Experience with Endoluminal Grafting to Treat Thoracic Aortic Aneurysms and Related Pathologies
4. Video: Actress and New Mom Keri Russell Joins PKIDs to Launch Silence the Sounds of Pertussis Campaign
5. Video: Quest Diagnostics Health Trends(TM) Report Shows Significant Gap in Care for Patients With Chronic Kidney Disease
6. Video: New Results From One of the Worlds Largest Breast Cancer Trials Herald Hope for Thousands of Women
7. VIDEO: Femara(R) helps protect against return of breast cancer even when treatment starts several years after completing tamoxifen therapy
8. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
9. Video: Major Independent Trial Demonstrates Significant Anticancer Benefit of Zometa(R) in Women With Early-Stage Breast Cancer
10. Video: Clinical Study Shows Liraglutide Reduced Blood Sugar, Weight, and Blood Pressure in Patients with Type 2 Diabetes
11. Video: Sanford Healths Journey to Cure Type 1 Diabetes Receives Major Boost
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/31/2015)... SAN FRANCISCO , Aug. 31, 2015  On ... District of Oregon denied motions ... Inc. (NASDAQ: GALE ) and certain of its ... had facilitated a "pump and dump" scheme to artificially ... trading period while the stock price was inflated, sold ...
(Date:8/31/2015)... 31, 2015  Regulatory affairs professionals work at ... are often strict and legislation is ever-changing. The ... for professionals who have a deep understanding of ... product lifecycle and demonstrate its use across various ... California, Irvine Extension , in partnership with the ...
(Date:8/31/2015)... Aug. 31, 2015 Regen BioPharma, Inc. (OTCBB: ... a novel means of delivering its patented (US ... liver tumors utilizing a clinically approved formulation as ... hurdles with gene silencing therapeutics in which the ... the whole body.  By utilizing a local delivery ...
Breaking Medicine Technology:Galena Biopharma, Inc. Stock Alert: Schubert Firm Investigates Potential Breaches of Fiduciary Duty 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 2UC Irvine Extension Launches New Regulatory Affairs and Compliance Certificate Program 3Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 2Regen BioPharma, Inc. Develops BORIS Gene Silencing Based Treatment for Unresectable Liver Cancer 3
... Ore.--(BUSINESS WIRE)--Jul 10, 2007 - AVI BioPharma, Inc.,(Nasdaq:AVII) ... target patient enrollment and released six-month,follow-up data from ... trial, currently being held in Germany, was designed ... Resten-MP(TM), when,used in conjunction with the placement of ...
... Fail to Demonstrate Meaningful Placebo Adjusted Weight,Loss; ... July 09, 2007 /PRNewswire-FirstCall/ -- Manhattan,Pharmaceuticals, Inc. ... 2a clinical trials of oral Oleoyl-estrone (OE). ... one,in common obesity and the other in ...
Cached Medicine Technology:AVI BioPharma Partner Cook Medical Announces Completion of Patient,Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of,Cardiovascular Disease 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 2Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 3Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for,Oral Oleoyl-estrone 4
(Date:9/1/2015)... ... September 01, 2015 , ... Dr. Trace Curry successfully placed one of ... In the last month the FDA has approved two intra-gastric balloons, the ORBERA ... represent the first incisionless, reversible, weight loss procedures available to Americans. , ...
(Date:9/1/2015)... ... September 01, 2015 , ... The integration of Practice ... from Practice Perfect to FOTO enabling cost and time savings, reducing errors and ... Presement, President of Practice Perfect, stated "FOTO is a natural extension of Practice ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... Anthony J. ... the Super Lawyers 2015 for his third consecutive year in a row. Through ... accomplishments of helping people. , Born in Niagara Falls, New York, Tantillo is a ...
(Date:9/1/2015)... (PRWEB) , ... September 01, 2015 , ... ... Zeel™, has recently sponsored an educational workshop for physician assistants (PAs) practicing in ... of Traumeel™ and Zeel™” was held by Dr. Erick Salado, an orthopedic surgeon ...
(Date:9/1/2015)... ... September 01, 2015 , ... The premier ... has become a leader in podiatric, surgical and wound care conferences ... Conferences place top national speakers at the podium and across the table during ...
Breaking Medicine News(10 mins):Health News:Dr. Trace Curry Performs First ORBERA™ Intra-gastric Balloon in Ohio at JourneyLite, a New Incisionless Option For The Treatment of Obesity 2Health News:FOTO Announces New Integration Partnership with Practice Perfect 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 2Health News:New Hope for Patients Seeking Treatment of Osteoarthritis Knee Pain 3Health News:PRESENT e-Learning Systems Announces their 2016 Podiatry and Wound Care Medical Education Conference Schedule 2
... cancers alive have made a world-first discovery that could ... , Western Australian Institute for Medical Research (WAIMR) Associate ... a gene called RGS5 can reverse angiogenesis the ... discovery is published in the most recent edition of ...
... U.S. Army launch program to extend the reach of their High ... School Dropout Prevention ,Boost, Campaign, NEW YORK, ... to launch a Wake-Up Call program as part of their "Boost",national ... school. Featuring the voice of Amare Stoudemire, NBA,All-Star and Captain of ...
... National Coalition to Tackle Number One Cause of ... Stressing the major toll that,chronic diseases take ... coalition of influential New Jersey residents in the ... New Jersey,Partnership to Fight Chronic Disease (PFCD), a ...
... good option , , WEDNESDAY, April 16 (HealthDay News) -- New ... vitamin D were found to have a higher incidence of ... arteries. , The study of nearly 4,900 American adults found ... the lowest levels of vitamin D compared to those with ...
... from osteoarthritis, with half a million Americans having a ... to be published in the April 2008 edition (Volume ... Research shows Pycnogenol (pic-noj-en-all), an antioxidant plant extract from ... shown to reduce all osteoarthritis symptoms by 56 percent. ...
... Presented at the Financial Communications Forum, New York, ... today named John,Hancock Retirement Plan Service,s "EZ Route" ... Insight Award for Customer Advocacy in,Financial Services. Sponsored ... session at the Financial Communications Forum in New ...
Cached Medicine News:Health News:World-first discovery could help treat life-threatening tumors 2Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 2Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 3Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 4Health News:Video: Phoenix Suns' Amare Stoudemire Kicks Off Program to Encourage Teens to 'Wake Up' and Go to School 5Health News:New Jersey Leaders Join Forces to Battle Chronic Disease 2Health News:New Jersey Leaders Join Forces to Battle Chronic Disease 3Health News:New Jersey Leaders Join Forces to Battle Chronic Disease 4Health News:Low Vitamin D Levels Linked to Leg Artery Blockages 2Health News:Low Vitamin D Levels Linked to Leg Artery Blockages 3Health News:Study shows pine bark naturally reduces osteoarthritis 2Health News:Study shows pine bark naturally reduces osteoarthritis 3Health News:Study shows pine bark naturally reduces osteoarthritis 4Health News:John Hancock's 'EZ Route' Post-Enrollment Education Program Wins 2008 Insight Award for Customer Advocacy in Financial Services 2
Open blade design with aspiration capabilities for removing fluids from the operative site. 19 gauge wire....
Designed to provide open approaches of the keratome to the cornea for either the left or right eye. Lightweight wire design adds to the comfort of the instrument when in place....
Solid 14 mm free-swinging blades, suture posts, and stabilizing disk. Dull finish....
Designed for use with foster enucleation snare (E3670). Package of 12 stainless steel wires. Overall length 5.3 inches....
Medicine Products: